Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 1 Diabetes When Given by an Insulin Pump
Sponsor: Novo Nordisk A/S
Summary
The study is looking at the effect and safety of a new fast-acting insulin (NNC0471 0119) to people with type 1 diabetes when given by an insulin pump. The study tests how fast insulin NNC0471-0119 enters your bloodstream, how long it stays there and how much it lowers blood sugar. The new insulin NNC0471-0119 will be compared to insulin aspart. The participants will get each study medicine administered at separate clinic visits. The study will last for about 1-3 months.
Official title: A Study Investigating the Pharmacokinetic and Pharmacodynamic Properties and Safety and Tolerability of NNC0471-0119 H When Administered as Bolus in a Continuous Subcutaneous Insulin Infusion Regimen in Participants With Type 1 Diabetes
Key Details
Gender
All
Age Range
18 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
43
Start Date
2025-01-29
Completion Date
2025-07-28
Last Updated
2026-09-10
Healthy Volunteers
No
Conditions
Interventions
NNC0471-0119 H
NNC0471-0119 H will be administered subcutaneously.
Insulin aspart
Insulin aspart will be administered subcutaneously.
Locations (1)
Profil Institut für Stoffwechselforschung GmbH
Neuss, Germany